Evidence map›Paper›PMID 35889230›Full record

ArticleMolecules (Basel, Switzerland)2022

Solubility Optimization of Loxoprofen as a Nonsteroidal Anti-Inflammatory Drug: Statistical Modeling and Optimization.

Mohammed Alqarni, Nader Ibrahim Namazi, Sameer Alshehri, Ibrahim A Naguib, Amal M Alsubaiyel, Kumar Venkatesan, Eman Mohamed Elmokadem, Mahboubeh Pishnamazi, Mohammed A S Abourehab

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohammed AlqarniDepartment of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia.ORCID 0000-0002-9028-2288
Nader Ibrahim NamaziPharmaceutics and Pharmaceutical Technology Department, College of Pharmacy, Taibah University, Al Madinah Al Munawarah 30001, Saudi Arabia.
Sameer AlshehriDepartment of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia.ORCID 0000-0003-2119-867X
Ibrahim A NaguibDepartment of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia.ORCID 0000-0002-5923-1466
Amal M AlsubaiyelDepartment of Pharmaceutics, College of Pharmacy, Qassim University, Buraidah 52571, Saudi Arabia.
Kumar VenkatesanDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.ORCID 0000-0001-5077-9380
Eman Mohamed ElmokademDepartment of Pharmacy Practice and Clinical Pharmacy, Faculty Pharmacy, Future University in Egypt, New Cario 11835, Egypt.
Mahboubeh PishnamaziInstitute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam.
Mohammed A S AbourehabDepartment of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0003-1348-6567

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Industrial-based application of supercritical CO

Indexed as

Anti-Inflammatory Agents, Non-SteroidalArtificial IntelligenceAnti-Inflammatory AgentsPhenylpropionatesSolubilityAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalloxoprofenPhenylpropionatesloxoprofenmachine learningoptimizationsolubilitysupercritical fluids

Identifiers

PMID35889230
PMCPMC9321224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.